# Nuo Therapeutics, Inc.: Form 8-K, filed Dec 5, 2022

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 8-K
- Filed: 2022-12-05
- Accepted by EDGAR: Dec 5, 2022, 21:30 ET
- Period: 2022-12-02
- Accession: 0001437749-22-028414
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922028414/aurx20221202b_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774922028414/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774922028414/aurx20221202b_8k.htm

Filed Dec 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001437749-22-028414. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.